Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

eBriefing

Translational Approaches for Human Liver Disease

Translational Approaches for Human Liver Disease
Reported by
Kristifor Sunderic

Posted May 15, 2018

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

Overview

Non-alcoholic steatohepatitis (NASH), a metabolic liver disorder characterized by fat deposition, inflammation, and insulin resistance, is the second leading cause of disease driving the need for liver transplantation in the United States. Currently, there are no approved treatments available. Scientists and clinicians have developed a better understanding of this disease state using animal models, targeted drugs, and risk alleles, but the development of human-translatable in vitro models of disease for drug metabolism and injury is still nascent, though data is growing. On February 20, 2018, the Biochemical Pharmacology Discussion Group at the New York Academy of Sciences presented Translational Approaches for Human Liver Diseases, a symposium on current and emerging in vitro model systems, covering potential benefits and limitations for the treatment of liver disease.

Speakers

Scott Friedman, MD, Icahn School of Medicine at Mount Sinai
Scott Friedman, MD, Icahn School of Medicine at Mount Sinai
Shyam Sundhar Bale, PhD, Draper Laboratory
Shyam Sundhar Bale, PhD, Draper Laboratory
Paulina Ordonez, MD, University of California, San Diego
Paulina Ordonez, MD, University of California, San Diego
Robert Schwartz, MD, PhD, Weill Cornell Medical College
Robert Schwartz, MD, PhD, Weill Cornell Medical College
Michael Shuler, PhD, Cornell University
Michael Shuler, PhD, Cornell University
Leah Norona, PhD, University of North Carolina, Chapel Hill
Leah Norona, PhD, University of North Carolina, Chapel Hill
Ernesto Guccione, PhD, Icahn School of Medicine at Mount Sinai
Ernesto Guccione, PhD, Icahn School of Medicine at Mount Sinai
In Vitro Models of Liver Injury
NASH and Tissue Models